VERU INC. Increase (Decrease) in Income Taxes Receivable
VERU INC. (VERU) reported Increase (Decrease) in Income Taxes Receivable of -$2.39 thousand for the 12-month period ending 2017-09-30, per its 10-K filed 2018-01-02.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInIncomeTaxesReceivable · last filed 2018-02-14
- VERU INC. increase (decrease) in income taxes receivable for the quarter ending 2017-09-30 was -$37.10K.
- VERU INC. increase (decrease) in income taxes receivable for the quarter ending 2017-06-30 was $34.88K.
- VERU INC. increase (decrease) in income taxes receivable for the quarter ending 2017-03-31 was $33.00, a 98.68% decline year-over-year.
- VERU INC. increase (decrease) in income taxes receivable for the quarter ending 2016-12-31 was -$191.00, a 103.21% decline year-over-year.
- VERU INC. increase (decrease) in income taxes receivable for fiscal 2017 was -$2.39K.
- VERU INC. increase (decrease) in income taxes receivable for fiscal 2016 was -$18.86K, a 188.77% decline from fiscal 2015.
- VERU INC. increase (decrease) in income taxes receivable for fiscal 2015 was $21.25K.
- VERU INC. increase (decrease) in income taxes receivable for fiscal 2014 was -$78.44K, a 253.59% decline from fiscal 2013.
| Period end | Increase (Decrease) in Income Taxes Receivable 3 month | Increase (Decrease) in Income Taxes Receivable 6 month | Increase (Decrease) in Income Taxes Receivable 9 month | Increase (Decrease) in Income Taxes Receivable 12 month |
|---|---|---|---|---|
| 2017-09-30 | -$37.10K derived: 10-K 12 month − 10-Q 9 month · filed 2018-01-02 | -$2.23K derived: sum of 2 quarters · filed 2018-01-02 | -$2.20K derived: sum of 3 quarters · filed 2018-01-02 | -$2.39K 10-K · filed 2018-01-02 |
| 2017-06-30 | $34.88K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-08-09 | $34.91K derived: sum of 2 quarters · filed 2017-08-09 | $34.72K 10-Q · filed 2017-08-09 | $8.10K derived: sum of 4 quarters · filed 2018-02-14 |
| 2017-03-31 | $33.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-05-10 | -$158.00 10-Q · filed 2017-05-10 | -$26.77K derived: sum of 3 quarters · filed 2018-02-14 | -$27.47K derived: sum of 4 quarters · filed 2018-02-14 |
| 2016-12-31 | -$191.00 10-Q · filed 2018-02-14 | -$26.80K derived: sum of 2 quarters · filed 2018-02-14 | -$27.51K derived: sum of 3 quarters · filed 2018-02-14 | -$25.00K derived: sum of 4 quarters · filed 2018-02-14 |
| 2016-09-30 | -$26.61K derived: 10-K 12 month − 10-Q 9 month · filed 2018-01-02 | -$27.32K derived: sum of 2 quarters · filed 2018-01-02 | -$24.81K derived: sum of 3 quarters · filed 2018-01-02 | -$18.86K 10-K · filed 2018-01-02 |
| 2016-06-30 | -$702.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-08-09 | $1.80K derived: sum of 2 quarters · filed 2017-08-09 | $7.75K 10-Q · filed 2017-08-09 | |
| 2016-03-31 | $2.51K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-05-10 | $8.45K 10-Q · filed 2017-05-10 | ||
| 2015-12-31 | $5.94K 10-Q · filed 2017-02-09 | |||
| 2015-09-30 | $21.25K 10-K · filed 2018-01-02 | |||
| 2014-09-30 | -$78.44K 10-K · filed 2016-12-12 | |||
| 2013-09-30 | $51.07K 10-K · filed 2015-12-02 | |||
| 2012-09-30 | $27.37K 10-K · filed 2014-12-02 | |||
| 2011-09-30 | -$28.18K 10-K · filed 2013-12-03 | |||
| 2010-09-30 | -$39.93K 10-K · filed 2012-12-04 | |||
| 2009-09-30 | $66.37K 10-K · filed 2011-12-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |